No abstract available
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / economics*
-
Antineoplastic Agents / therapeutic use*
-
Cost-Benefit Analysis
-
Drug Costs*
-
Health Services Accessibility / economics*
-
Healthcare Disparities / economics*
-
Humans
-
Medical Oncology / economics*
-
Neoplasms / drug therapy*
-
Neoplasms / economics*
-
Practice Patterns, Physicians' / economics
-
Quality-Adjusted Life Years
-
Time Factors
-
Treatment Outcome
-
Value of Life